Ortho-Hydroxy Tryptophan Lanreotide - Solicitar cotización

Ortho-Hydroxy Tryptophan Lanreotide is chemically (4R,7S,10S,13R,16S,19R)-19-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-10-(4-aminobutyl)-13-((7-hydroxy-1H-indol-3-yl)methyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide. Ortho-Hydroxy Tryptophan Lanreotide is supplied with detailed characterization data compliant with regulatory guideline. Ortho-Hydroxy Tryptophan Lanreotide can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lanreotide.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.